1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Mark H. Einstein: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers Celecoxib - Uterine Cancer | Phase 2 | Terminated | Mark H. Einstein | 23 | 2003-04-01 | 2012-04-24 |
Adenocarcinoma, Clear Cell (1) · Uterine Neoplasms (1)
Celecoxib (1)
United States (1)